share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Finucane Anne A.

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Finucane Anne A.

西維斯健康 | 4:持股變動聲明-董事 Finucane Anne A.
美股SEC公告 ·  05/18 05:43

牛牛AI助理已提取核心訊息

Anne A. Finucane, associated with CVS Health Corp, was involved in a transaction concerning the company's common stock on 05/16/2024. Following the transaction, Finucane directly holds 7,232.2482 shares of CVS Health. Additionally, the Finucane Family Trust indirectly holds 25,198 shares. The nature of the shares held indicates a direct ownership for some and an indirect ownership through the family trust for others. The transaction reaffirms Finucane's stake in CVS Health, although the specific details of the transaction, such as the number of shares bought or sold and the transaction price, were not disclosed.
Anne A. Finucane, associated with CVS Health Corp, was involved in a transaction concerning the company's common stock on 05/16/2024. Following the transaction, Finucane directly holds 7,232.2482 shares of CVS Health. Additionally, the Finucane Family Trust indirectly holds 25,198 shares. The nature of the shares held indicates a direct ownership for some and an indirect ownership through the family trust for others. The transaction reaffirms Finucane's stake in CVS Health, although the specific details of the transaction, such as the number of shares bought or sold and the transaction price, were not disclosed.
與CVS Health Corp有聯繫的安妮·菲紐肯於2024年5月16日參與了一項有關該公司普通股的交易。交易完成後,Finucane直接持有CVS Health的7,232.2482股股份。此外,菲紐肯家族信託基金間接持有25,198股股票。所持股份的性質表明,一些人擁有直接所有權,另一些人通過家族信託獲得間接所有權。該交易重申了Finucane在CVS Health的股份,儘管該交易的具體細節,例如買入或賣出的股票數量和交易價格,尚未披露。
與CVS Health Corp有聯繫的安妮·菲紐肯於2024年5月16日參與了一項有關該公司普通股的交易。交易完成後,Finucane直接持有CVS Health的7,232.2482股股份。此外,菲紐肯家族信託基金間接持有25,198股股票。所持股份的性質表明,一些人擁有直接所有權,另一些人通過家族信託獲得間接所有權。該交易重申了Finucane在CVS Health的股份,儘管該交易的具體細節,例如買入或賣出的股票數量和交易價格,尚未披露。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。